Ventyx Biosciences, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q3 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Ventyx Biosciences, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q3 2020 to Q3 2024.
  • Ventyx Biosciences, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$35.2M, a 34.8% increase year-over-year.
  • Ventyx Biosciences, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$153M, a 15.9% increase year-over-year.
  • Ventyx Biosciences, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$193M, a 78% decline from 2022.
  • Ventyx Biosciences, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$108M, a 29.5% decline from 2021.
  • Ventyx Biosciences, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$83.7M, a 197% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$153M -$35.2M +$18.8M +34.8% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 -$171M -$32M +$21.3M +40% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 -$193M -$38.6M +$359K +0.92% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$193M -$46.8M -$11.5M -32.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-27
Q3 2023 -$181M -$54M -$23.6M -77.4% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 -$158M -$53.3M -$33.2M -166% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$125M -$38.9M -$16.2M -71.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$108M -$35.2M -$17.4M -98.2% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-27
Q3 2022 -$91M -$30.5M -$17.7M -138% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$73.3M -$20M -$4.46M -28.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$68.8M -$22.7M +$14.9M +39.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$83.7M -$17.8M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-23
Q3 2021 -$12.8M -$5.62M -78.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-04
Q2 2021 -$15.6M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$37.6M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q3 2020 -$7.16M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.